About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (35)
View allTotal Trials
35
As Lead Sponsor
26
As Collaborator
9
Total Enrollment
12,044
By Phase
PHASE3: 8PHASE2/PHASE3: 1PHASE1: 4NA: 4PHASE2: 11PHASE4: 3
By Status
COMPLETED: 16TERMINATED: 7ACTIVE_NOT_RECRUITING: 4RECRUITING: 3UNKNOWN: 3NOT_YET_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline35 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07025681Lead Sponsor
PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).
PHASE3Recruiting
56 participants
Started: Apr 24, 2025 · Completed: Dec 31, 2025
NCT06616961Collaborator
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
PHASE3Not yet recruiting
480 participants
Started: Nov 1, 2024 · Completed: Oct 31, 2026
NCT06121375Lead Sponsor
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
PHASE2/PHASE3Active, not recruiting
144 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2025
NCT06488911Lead Sponsor
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
PHASE3Active, not recruiting
133 participants
Started: Jul 1, 2024 · Completed: Oct 31, 2025
NCT06305416Lead Sponsor
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
PHASE3Recruiting
70 participants
Started: Mar 30, 2024 · Completed: Dec 31, 2025
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...